Stevanato Group S.p.A. revenue for the last year amounted to 1.20 B USD, the most of which — 950.62 M USD — came from its highest performing source at the moment, Biopharmaceutical and Diagnostic Solutions, the year earlier bringing 840.46 M USD. The greatest contribution to the revenue figure was made by EMEA — last year it brought Stevanato Group S.p.A. 685.54 M USD, and the year before that — 630.27 M USD.